title: The burden of symptoms in myelofibrosis: from patient-reported outcomes to health economics.
authors.forename: Lisa
authors.initials: L
authors.lastname: Pieri
authors.forename: Idalba
authors.initials: I
authors.lastname: Loiacono
authors.forename: Alessandro M
authors.initials: AM
authors.lastname: Vannucchi
mesh_terms: D017281:Cost of Illness; D017048:Health Care Costs; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D009570:Nitriles; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000191:economics / Q000473:pathology; D011720:Pyrazoles / Q000191:economics / Q000627:therapeutic use*; D011743:Pyrimidines; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases